(1)
Lebwohl, M.; Warren, R. B.; Sofen, H.; Imafuku, S.; Paul, C.; Szepietowski, J. C.; Spelman, L.; Passeron, T.; Colston, E.; Hippeli, L.; Napoli, A.; Kisa, R. M.; Banerjee, S.; Menter, A.; Thaçi, D.; Blauvelt, A. Deucravacitinib Long-Term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results from the Phase 3 POETYK PSO Program. J of Skin 2023, 7, s118.